A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled Cross-over Efficacy And Safety Study Of Pregabalin In The Treatment Of Patients With Painful Diabetic Peripheral Neuropathy And Pain On Walking
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2015
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Pain
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 18 Oct 2013 Primary endpoint 'Pain-relief' has not been met.
- 18 Oct 2013 Primary endpoint 'Pain-on-movement' has not been met.
- 17 Oct 2013 Results published in the Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History